Beijing Bio-Targeting Therapeutics Technology Co., Ltd
4 clinical trials · Sponsor
◉ Watch Beijing Bio-Targeting Therapeutics Technology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma (NCT07472790) | Beijing Bio-Targeting Therapeutics Technology Co., Ltd | 2026-07-31 |
| A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer (NCT07150767) | Beijing Bio-Targeting Therapeutics Technology Co., Ltd | 2025-03-26 |
| Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma. (NCT06763965) | Beijing Bio-Targeting Therapeutics Technology Co., Ltd | 2024-11-26 |
| A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors (NCT06215846) | Beijing Bio-Targeting Therapeutics Technology Co., Ltd | 2024-05-07 |
Track Beijing Bio-Targeting Therapeutics Technology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.